Loading…
Reported covered position: Legislative Director, Rep. Ben Ray Lujan; Legislative Counsel, Rep. Ruben Hinojosa
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
HR 2199/S 1173, the Restore Protections for Dialysis Patients Act CMS Kidney Care Choices model Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
HR 2199/S 1173, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
DAVITA, INC via APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
2026 · third_quarter · Q3
HR 2199/S 1173, Restore Protections for Dialysis Patients Act. Issues related to access to treatment for End Stage Renal Disease (ESRD).
HR 2199/S 1173, the Restore Protections for Dialysis Patients Act CMS Kidney Care Choices model Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Source: Senate LDA
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
HR 2199/S 1173, the Restore Protections for Dialysis Patients Act CMS Kidney Care Choices model Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
HR 2199/S 1173, Restore Protections for Dialysis Patients Act. Issues related to access to treatment for End Stage Renal Disease (ESRD).
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Innovative FEED Act of 2025
Client: ANZU STRATEGIES (OBO ELANCO US INC) · Firm: APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025 Issues pertaining to conservation programs and agricultural markets
Innovative FEED Act of 2025
Client: ANZU STRATEGIES (OBO ELANCO US INC) · Firm: APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025
Innovative FEED Act of 2025
Client: ANZU STRATEGIES (OBO ELANCO US INC) · Firm: APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025
Innovative FEED Act of 2025
Client: ANZU STRATEGIES (OBO ELANCO US INC) · Firm: APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025 Issues pertaining to conservation programs and agricultural markets
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
HR 2199/S 1173, the Restore Protections for Dialysis Patients Act CMS Kidney Care Choices model Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
HR 2199/S 1173, Restore Protections for Dialysis Patients Act. Issues related to access to treatment for End Stage Renal Disease (ESRD).
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
HR 2199/S 1173, the Restore Protections for Dialysis Patients Act CMS Kidney Care Choices model Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
HR 2199/S 1173, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS
HR 2199, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS
HR 2199, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS
HR 2199, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS
HR 2199, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS
HR 2199, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS
HR 2199, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS
HR 2199/S 1173, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS
HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Innovative FEED Act of 2025
Client: ANZU STRATEGIES (OBO ELANCO US INC) · Firm: APOLLO GOVERNMENT RELATIONS
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025 Issues pertaining to conservation programs and agricultural markets
Innovative FEED Act of 2025
Client: ANZU STRATEGIES (OBO ELANCO US INC) · Firm: APOLLO GOVERNMENT RELATIONS
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025 Issues pertaining to conservation programs and agricultural markets
Innovative FEED Act of 2025
Client: ANZU STRATEGIES (OBO ELANCO US INC) · Firm: APOLLO GOVERNMENT RELATIONS
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025
Innovative FEED Act of 2025
Client: ANZU STRATEGIES (OBO ELANCO US INC) · Firm: APOLLO GOVERNMENT RELATIONS
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025 Issues pertaining to conservation programs and agricultural markets
Innovative FEED Act of 2025
Client: ANZU STRATEGIES (OBO ELANCO US INC) · Firm: APOLLO GOVERNMENT RELATIONS
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025
Innovative FEED Act of 2025
Client: ANZU STRATEGIES (OBO ELANCO US INC) · Firm: APOLLO GOVERNMENT RELATIONS
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025 Issues pertaining to conservation programs and agricultural markets
Innovative FEED Act of 2025
Client: ANZU STRATEGIES (OBO ELANCO US INC) · Firm: APOLLO GOVERNMENT RELATIONS
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025
Innovative FEED Act of 2025
Client: ANZU STRATEGIES (OBO ELANCO US INC) · Firm: APOLLO GOVERNMENT RELATIONS
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS
HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS
HR 2199/S 1173, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
H.R. 6860/S.5018, Restore Protections for Dialysis Patients Act H.R. 5074/S.4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
H.R. 6860/S.5018, Restore Protections for Dialysis Patients Act H.R. 5074/S.4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act H.R. 5074/S. 4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act H.R. 5074/S. 4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS
H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act H.R. 5074/S. 4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS
H.R. 6860/S.5018, Restore Protections for Dialysis Patients Act H.R. 5074/S.4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS
H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act H.R. 5074/S. 4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS
H.R. 6860/S.5018, Restore Protections for Dialysis Patients Act H.R. 5074/S.4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
H.R. 6860/S.5018, Restore Protections for Dialysis Patients Act H.R. 5074/S.4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act H.R. 5074/S. 4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act H.R. 5074/S. 4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
H.R. 6860/S.5018, Restore Protections for Dialysis Patients Act H.R. 5074/S.4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS
H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act H.R. 5074/S. 4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS
H.R. 6860/S.5018, Restore Protections for Dialysis Patients Act H.R. 5074/S.4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS
H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act H.R. 5074/S. 4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Restore Protections for Dialysis Patients Act
Client: DAVITA, INC · Firm: APOLLO GOVERNMENT RELATIONS
H.R. 6860/S.5018, Restore Protections for Dialysis Patients Act H.R. 5074/S.4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
DAVITA, INC via APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
2026 · second_quarter · Q2
HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
HR 2199/S 1173, the Restore Protections for Dialysis Patients Act CMS Kidney Care Choices model Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANZU STRATEGIES (OBO ELANCO US INC) via APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
2026 · second_quarter · 2T
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025 Issues pertaining to conservation programs and agricultural markets
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANZU STRATEGIES (OBO ELANCO US INC) via APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
2026 · first_quarter · Q1
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025 Issues pertaining to conservation programs and agricultural markets
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA, INC via APOLLO GOVERNMENT RELATIONS (D/B/A APOLLO COUNSEL)
2026 · first_quarter · Q1
HR 2199/S 1173, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANZU STRATEGIES (OBO ELANCO US INC) via APOLLO GOVERNMENT RELATIONS
2025 · fourth_quarter · Q4
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025 Issues pertaining to conservation programs and agricultural markets
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA, INC via APOLLO GOVERNMENT RELATIONS
2025 · fourth_quarter · Q4
HR 2199/S 1173, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
HR 2199/S 1173, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANZU STRATEGIES (OBO ELANCO US INC) via APOLLO GOVERNMENT RELATIONS
2025 · third_quarter · Q3
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025 Issues pertaining to conservation programs and agricultural markets
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA, INC via APOLLO GOVERNMENT RELATIONS
2025 · third_quarter · Q3
HR 2199, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
HR 2199, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANZU STRATEGIES (OBO ELANCO US INC) via APOLLO GOVERNMENT RELATIONS
2025 · second_quarter · Q2
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025 Issues pertaining to conservation programs and agricultural markets
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA, INC via APOLLO GOVERNMENT RELATIONS
2025 · second_quarter · Q2
HR 2199, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
HR 2199, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANZU STRATEGIES (OBO ELANCO US INC) via APOLLO GOVERNMENT RELATIONS
2025 · first_quarter · Q1
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025
H.R. 2203, Innovative Feed Enhancement and Economic Development Act of 2025 Issues pertaining to conservation programs and agricultural markets
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA, INC via APOLLO GOVERNMENT RELATIONS
2025 · first_quarter · Q1
HR 2199, Restore Protections for Dialysis Patients Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
HR 2199, the Restore Protections for Dialysis Patients Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ANZU STRATEGIES (OBO ELANCO US INC) via APOLLO GOVERNMENT RELATIONS
2025 · first_quarter · RR
Issues related to animal health
Issues related to animal health
DAVITA, INC via APOLLO GOVERNMENT RELATIONS
2024 · third_quarter · Q3
H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act H.R. 5074/S. 4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
H.R. 6860/S.5018, Restore Protections for Dialysis Patients Act H.R. 5074/S.4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA, INC via APOLLO GOVERNMENT RELATIONS
2024 · fourth_quarter · Q4
H.R. 6860/S.5018, Restore Protections for Dialysis Patients Act H.R. 5074/S.4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act Issues related to access to treatment for End Stage Renal Disease (ESRD)
H.R. 6860/S. 5018, Restore Protections for Dialysis Patients Act H.R. 5074/S. 4510, the Kidney Patient Access to Technologically Innovative and Essential Nephrology Treatments (PATIENT) Act Issues related to reimbursement for treatment of End Stage Renal Disease (ESRD)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DAVITA, INC via APOLLO GOVERNMENT RELATIONS
2024 · third_quarter · RR
Access to healthcare services
Access to healthcare services